Expands investigation into UnitedHealth's Optum Rx by the Department of Justice
The U.S. Department of Justice's (DOJ) Criminal Division is currently conducting an investigation into the business practices of UnitedHealth Group's Pharmacy Benefit Manager, Optum Rx. This ongoing probe, first reported by Bloomberg News on Tuesday, is focused on Optum Rx's prescription management services and specifically how it reimburses its own doctors.
Sources familiar with the matter have confirmed the investigation, but it's important to note that the report does not yet specify any alleged wrongdoing or findings in the investigation. The investigation is not extending to any other pharmacy benefit manager or company, as stated in the report.
The investigation is not about the overall operations of UnitedHealth Group, but specifically about Optum Rx. The investigators are examining various aspects of Optum Rx's business practices, with a particular focus on its reimbursement methods.
This investigation was reported by Bloomberg News on Tuesday and has since been confirmed by sources close to the matter. The DOJ's criminal division is the investigating body, and the sources have asked to remain anonymous due to the sensitive nature of the investigation.
As the investigation continues, more details may emerge. However, at this time, the investigation remains an ongoing probe into UnitedHealth Group's operations, specifically into its Pharmacy Benefit Manager, Optum Rx. The public will be updated as more information becomes available.
